ARTV — Artiva Biotherapeutics

Median target
$11.58
calls from the last 12 months
Implied return
+175.7%
median target vs. price
Coverage
1 analysts · 1 calls
updated in the last 12 months
Consensus
1/0/0+1 net
Buy / Hold / Sell

Which analysts are behind ARTV's consensus?

See every current rating, price target and the analysts' track records for Artiva Biotherapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 1 analysts with calls on ARTV updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ARTV elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-11-02InsidersAslan FredChief Executive OfficerInsider sale62.2K sh @ $4.18$260K
2026-11-02InsidersHoran ChristopherChief Tech Operations OfInsider sale10.4K sh @ $4.18$44K
2026-11-02InsidersBush JenniferCOO, CLO, Compliance OffInsider sale8.4K sh @ $4.18$35K
2026-11-02InsidersBanerjee SubhashisChief Medical OfficerInsider sale1.1K sh @ $4.18$5K
2026-10-06InsidersAslan FredChief Executive OfficerInsider sale23.5K sh @ $7.20 · planned trade$169K
2026-10-05InsidersAslan FredChief Executive OfficerInsider sale61.7K sh @ $6.84$422K
2026-10-05InsidersHoran ChristopherChief Tech Operations OfInsider sale10.3K sh @ $6.84$71K
2026-10-05InsidersBush JenniferCOO, CLO, Compliance OffInsider sale8.4K sh @ $6.84$57K
2026-10-05InsidersBanerjee SubhashisChief Medical OfficerInsider sale1.1K sh @ $6.84$8K
2026-09-08InsidersAslan FredDirector,OfficerInsider sale23.4K sh @ $10.92 · planned trade$256K

More: insider activity · executive branch · trending